- Home
- CLWT vs INAB Comparison
CLWT vs INAB Comparison
Compare CLWT & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLWT
- INAB
- Stock Information
- Founded
- CLWT 1971
- INAB 2016
- Country
- CLWT Hong Kong
- INAB United States
- Employees
- CLWT N/A
- INAB N/A
- Industry
- CLWT Professional and commerical equipment
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- CLWT Consumer Discretionary
- INAB Health Care
- Exchange
- CLWT Nasdaq
- INAB Nasdaq
- Market Cap
- CLWT 9.4M
- INAB 10.6M
- IPO Year
- CLWT 1997
- INAB 2021
- Fundamental
- Price
- CLWT $1.22
- INAB $2.01
- Analyst Decision
- CLWT
- INAB Strong Buy
- Analyst Count
- CLWT 0
- INAB 2
- Target Price
- CLWT N/A
- INAB $108.00
- AVG Volume (30 Days)
- CLWT 68.2K
- INAB 66.8K
- Earning Date
- CLWT 01-01-0001
- INAB 11-10-2025
- Dividend Yield
- CLWT N/A
- INAB N/A
- EPS Growth
- CLWT N/A
- INAB N/A
- EPS
- CLWT 0.10
- INAB N/A
- Revenue
- CLWT $15,383,000.00
- INAB N/A
- Revenue This Year
- CLWT N/A
- INAB N/A
- Revenue Next Year
- CLWT N/A
- INAB N/A
- P/E Ratio
- CLWT $12.83
- INAB N/A
- Revenue Growth
- CLWT N/A
- INAB N/A
- 52 Week Low
- CLWT $1.01
- INAB $1.91
- 52 Week High
- CLWT $1.63
- INAB $12.53
- Technical
- Relative Strength Index (RSI)
- CLWT 41.94
- INAB 43.09
- Support Level
- CLWT $1.22
- INAB $1.98
- Resistance Level
- CLWT $1.27
- INAB $2.15
- Average True Range (ATR)
- CLWT 0.04
- INAB 0.10
- MACD
- CLWT -0.01
- INAB -0.01
- Stochastic Oscillator
- CLWT 8.90
- INAB 22.32
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.